SHERYL GOODALL: Open Payments
NPI 1518948629 · BROCKTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$282 in 23 payments from 7 companies in 2025. Trend: 2023 $811 · 2024 $1,218 · 2025 $282
Food & beverage: $282
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $136 |
| Otsuka America Pharmaceutical, Inc. | 3 | $50 |
| ABBVIE INC. | 2 | $35 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Alkermes, Inc. | 1 | $16 |
| Neurocrine BioSciences, Inc. | 1 | $15 |
| Corium, LLC | 1 | $12 |
Products named: CAPLYTA, REXULTI, VRAYLAR, Auvelity, ARISTADA, INGREZZA, Azstarys.
Industry payments across MA — which companies pay providers there.
